report
US tariffs trigger 123% Singapore pharma output surge
US tariffs trigger 123% Singapore pharma output surge
Combined US and China markets account for 38% of all Singapore pharma exports.
4 hours ago
Industrial policy to reshape global health product value chains over five years
Policy reaches to extend from raw materials to procurement.
5 days ago
Human microbiome drugs market to be valued at $2.13b by 2031
By end users, the hospitals & clinics segment held the largest market share in 2024.
Genomic biomarkers market to reach $50.31b by 2030
Thanks to rapid developments in next-generation sequencing and multi-omics.
India’s hospital sector poised for up to 12% CAGR over next 3-5 years
Healthcare expenditure increased by 9.8% YoY in the Union Budget FY26.
Vagus nerve stimulation market to be valued at $23.73b by 2031
Development in minimally invasive solutions drives the sector.
Cryopreservation freezer market to be valued at $840m by 2031
The expansion of biobanking activities serves as a key driver for market growth.
Next-generation sequencing services market to reach $8.77b by 2030
The growing use of precision medicine and genomics drives the sector.
Asia-Pacific to see fastest growth in SMRT sequencing through 2030
Thanks to rising public and private investment in genomics.
What lies ahead for Taiwan’s pacemakers market?
Adoption is also likely to accelerate across high-volume cardiac centres.
7MM age-related macular degeneration market to reach $20.5b by 2034
Its growth is supported by the anticipated launch of 26 new pipeline agents.
Respiratory CGT development remains limited as funding drops
However, R&D efforts on automation and AI are advancing manufacturing.
Respiratory inhaler devices market to hit $51.9b by 2034
Key drivers include developments in smart and sustainable designs.
India’s ultrasound systems market to reach $263m by 2034
The country accounted for 7% of the Asia Pacific market in 2025.
Breast cancer drugs market to be valued at $57.1b by 2031
By end user, hospitals accounted for about 46% of the total market value.
India’s cardiovascular monitoring devices market to reach $153m in 2036
The country represents 7% of the Asia-Pacific market in 2025.
What lies ahead for the cell and gene therapy market?
Major investors have committed over $3.5b across cumulative deals.
Most Read
1. Health Information Bill compels providers to share patient data 2. US tariffs trigger 123% Singapore pharma output surge 3. Australia commits $80.33m to 60 medical research projects 4. Gleneagles scales Johor operations as medical tourism jumps 66% 5. Agentic AI to unlock $120m in healthcare system savingsResource Center
Read Here
Advertise
Sign Up
Events
Event News
Healthcare Asia Awards 2025 Winner: Lee Ligang Zhang of iKang Healthcare Group
Lee Ligang Zhang of iKang Healthcare Group highlights how AI and precision diagnosis are transforming healthcare delivery today.
